Insider Selling: Palomar (NASDAQ:PLMR) COO Sells $163,367.45 in Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) COO Rodolphe Herve sold 1,207 shares of the stock in a transaction that occurred on Friday, July 31st. The stock was sold at an average price of $135.35, for a total transaction of $163,367.45. Following the completion of the sale, the chief operating officer directly owned 3,548 shares of the company’s stock, valued at $480,221.80. This trade represents a 25.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Palomar Stock Performance

Shares of PLMR opened at $136.82 on Friday. The company’s 50 day moving average price is $126.23 and its 200 day moving average price is $123.66. Palomar Holdings, Inc. has a 52 week low of $100.81 and a 52 week high of $147.62. The company has a market capitalization of $3.63 billion, a PE ratio of 18.39 and a beta of 0.40. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.49 and a current ratio of 0.50.

Palomar (NASDAQ:PLMR) last released its earnings results on Tuesday, August 4th. The company reported $2.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.19 by $0.17. The company had revenue of $314.42 million during the quarter, compared to the consensus estimate of $621.52 million. Palomar had a net margin of 18.61% and a return on equity of 23.28%. During the same quarter in the prior year, the firm earned $1.76 EPS. Research analysts expect that Palomar Holdings, Inc. will post 8.9 EPS for the current fiscal year.

Palomar Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 2nd. Investors of record on Wednesday, August 19th will be issued a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a dividend yield of 1.3%. The ex-dividend date is Wednesday, August 19th.

Key Palomar News

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Palomar reported second-quarter EPS of $2.36, exceeding the $2.19 consensus estimate and rising from $1.76 a year earlier. Results benefited from higher premiums and increased investment income. Palomar Q2 earnings report
• Positive Sentiment: Management is targeting $270 million to $280 million of adjusted net income and raised its 2026 crop premium outlook to more than $400 million. The guidance highlights continued expansion and diversification, particularly in crop insurance. Palomar profit and crop premium guidance
• Positive Sentiment: Palomar initiated a quarterly dividend of $0.45 per share, payable September 2 to shareholders of record August 19. The dividend adds shareholder returns and signals confidence in the company’s cash-generation outlook. Palomar dividend announcement
• Neutral Sentiment: Analyst estimates were mixed: Zacks raised its FY2027 EPS forecast slightly to $9.70 from $9.66 and increased its Q1 2027 estimate to $2.22, but reduced estimates for Q1 and Q2 2028. Zacks maintained a “Hold” rating, suggesting limited conviction despite the near-term earnings strength. Palomar EPS estimate revisions
• Negative Sentiment: Higher claims losses and operating expenses pressured underwriting margins. Investors may view the strong premium growth cautiously if it does not translate into sustained underwriting profitability. Palomar Q2 business outlook
• Neutral Sentiment: COO Rodolphe Herve sold 1,207 shares for approximately $163,000 to cover tax-withholding obligations related to vested equity awards. Because the sale was administrative in nature, it is less likely to signal a negative view of PLMR. Palomar insider transaction filing

Institutional Trading of Palomar

A number of institutional investors and hedge funds have recently modified their holdings of PLMR. Global Retirement Partners LLC bought a new stake in shares of Palomar during the 2nd quarter worth $123,000. Bank of New York Mellon Corp bought a new position in Palomar in the 2nd quarter worth $30,966,000. GSA Capital Partners LLP acquired a new position in Palomar during the 2nd quarter worth $496,000. PVG Asset Management Corp lifted its position in Palomar by 526.4% during the 1st quarter. PVG Asset Management Corp now owns 10,147 shares of the company’s stock worth $1,147,000 after acquiring an additional 8,527 shares during the last quarter. Finally, Parallel Advisors LLC boosted its holdings in Palomar by 638.3% during the first quarter. Parallel Advisors LLC now owns 443 shares of the company’s stock valued at $53,000 after acquiring an additional 383 shares during the period. 90.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have commented on PLMR. Zacks Research downgraded Palomar from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 15th. Evercore set a $152.00 price target on Palomar in a research note on Friday, July 10th. Keefe, Bruyette & Woods lifted their price target on Palomar from $162.00 to $166.00 and gave the company an “outperform” rating in a report on Wednesday, July 8th. Weiss Ratings raised Palomar from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, June 18th. Finally, Piper Sandler boosted their price target on Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a research note on Wednesday, July 15th. Four research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Palomar presently has an average rating of “Moderate Buy” and a consensus price target of $162.50.

Palomar Company Profile

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.